Coverage
-
November 05, 2020
An Illinois federal judge won't give Actavis Inc. a quick win on claims that one of its testosterone drugs led to a user's stroke, finding that the company's duty to warn is not limited to a U.S. Food and Drug Administration-approved insert in the drug's packaging.
38 other articles on this case.
View all »